BioMarin Pharmaceutical Inc.
BMRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $427 | $168 | $142 | -$64 |
| Dep. & Amort. | $96 | $104 | $102 | $108 |
| Deferred Tax | $56 | -$45 | -$52 | -$16 |
| Stock-Based Comp. | $202 | $0 | $0 | $197 |
| Change in WC | -$216 | -$337 | -$96 | $66 |
| Other Non-Cash | $8 | $269 | $81 | $13 |
| Operating Cash Flow | $573 | $159 | $176 | $305 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$85 | -$108 | -$132 | -$96 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$410 | -$868 | -$612 | -$937 |
| Inv. Sales/Matur. | $633 | $865 | $620 | $691 |
| Other Inv. Act. | -$1 | $0 | $103 | -$25 |
| Investing Cash Flow | $136 | -$111 | -$20 | -$366 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$495 | -$2 | -$3 | -$3 |
| Stock Issued | $0 | $69 | $69 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$31 | -$86 | -$85 | $3 |
| Financing Cash Flow | -$526 | -$19 | -$19 | -$0 |
| Forex Effect | $5 | $1 | $0 | -$0 |
| Net Chg. in Cash | $188 | $31 | $137 | -$62 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $755 | $725 | $587 | $649 |
| End Cash | $943 | $755 | $725 | $587 |
| Free Cash Flow | $475 | $63 | $55 | $185 |